Evidence map›Paper›PMID 38787268›Full record

Trial reportPathogens (Basel, Switzerland)2024

Improved Treatment Outcome Following the Use of a Wound Dressings in Cutaneous Leishmaniasis Lesions.

Pedro B Borba, Jamile Lago, Tainã Lago, Mariana Araújo-Pereira, Artur T L Queiroz, Hernane S Barud, Lucas P Carvalho, Paulo R L Machado, Edgar M Carvalho, Camila I de Oliveira

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pedro B BorbaInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, Brazil.
Jamile LagoServiço de Imunologia, HUPES-UFBA, Salvador 40110-060, BA, Brazil.
Tainã LagoServiço de Imunologia, HUPES-UFBA, Salvador 40110-060, BA, Brazil.
Mariana Araújo-PereiraMultinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER Initiative), Salvador 41720-200, BA, Brazil.
Artur T L QueirozInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, Brazil.
Hernane S BarudLaboratório de BioPolímeros e Biomateriais, Uniara, Araraquara 14801-340, SP, Brazil.
Lucas P CarvalhoInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, Brazil.ORCID 0000-0001-5033-1666
Paulo R L MachadoServiço de Imunologia, HUPES-UFBA, Salvador 40110-060, BA, Brazil.ORCID 0000-0003-1894-6171
Edgar M CarvalhoInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, Brazil.ORCID 0000-0002-2697-8002
Camila I de OliveiraInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, Brazil.ORCID 0000-0002-7868-5164

Funding

National Council for Scientific and Technological Development 440107/2018-0National Council for Scientific and Technological Development Grant: 309614/2021-0National Council for Scientific and Technological Development (INCT-DT) #465229/2014-0
6 · The paper itself

Abstract

Leishmaniasis, caused by

Indexed as

BandagesLeishmaniasis, CutaneousMeglumine AntimoniateWound HealingAdolescentAdultAntiprotozoal AgentsBrazilCelluloseFemaleHumansLeishmania braziliensisMaleMiddle AgedTreatment OutcomeYoung AdultAntiprotozoal AgentsCelluloseMeglumine AntimoniateLeishmania braziliensismeglumine antimoniateskin lesiontopical therapywound dressing

Identifiers

PMID38787268
PMCPMC11124396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.